The HIV-1 Gag matrix (MA) domain mediates localization of Gag to the plasma membrane (PM), the site 15 for infectious virion assembly. The MA highly basic region (HBR) interacts with phosphatidylinositol-16 (4,5)-bisphosphate [PI(4,5)P2], a PM-specific acidic lipid. MA-HBR also binds RNAs. To test whether 17 acidic lipids alone determine PM-specific localization of Gag or whether MA-RNA binding also plays a 18 role, we compared a panel of MA-HBR mutants that contain two types of substitutions at MA residues 19 25/26 or 29/31: Lys->Arg (KR) (25/26KR and 29/31KR) and Lys->Thr (KT) (25/26KT and 29/31KT). 20
Introduction 45
HIV-1 progeny virions exit most cells at the plasma membrane (PM) (1, 2) . The matrix (MA) 46 domain of the HIV-1 structural polyprotein Gag mediates the targeting and binding of Gag to the PM, 47 which is a crucial stage of virus particle production (3-9). The two essential features of the MA domain 48 required for the PM-specific localization and binding of Gag are an N-terminal myristate moiety and a 49 highly basic region (HBR) (10-16). The myristoyl moiety allows Gag to form hydrophobic interactions 50 with membranes when it is not sequestered in the MA globular domain (17) (18) (19) (20) (21) (22) (23) (24) . The MA-HBR comprises 51 a highly conserved cluster of basic residues spanning residues 14-31 (13, 14, 23, 25) . This basic patch 52 drives electrostatic and head group-specific interactions of Gag with phosphatidylinositol (4,5)-53 bisphosphate [PI(4,5)P2], an acidic phospholipid found primarily in the inner leaflet of the PM (15, 20, 54 26-34) . In addition to acidic phospholipids, RNA, which has been shown to bind the MA domain (35) (36) (37) (38) (39) (40) (41) (42) (43) , 55 may play an important role in regulation of 32, [44] [45] [46] [47] [48] . Among the HBR 56 basic residues, an NMR-based study showed that the residues 29 and 31 are particularly important for 57 PI(4,5)P2 interaction in the absence of RNA (49) . 58 WT Gag that is translated in vitro using rabbit reticulocyte lysates binds liposomes consisting of a 59 neutral lipid, phosphatidylcholine (PC), and an acidic lipid, phosphatidylserine (PS) (PC+PS liposomes) 60 poorly but shows enhanced membrane binding either when Gag is treated with RNase or when PI(4,5)P2 61 is included in the liposomes (32, 50) . Furthermore, besides NC, MA-HBR mediates RNA binding to WT 62 Gag in the cytosol, and removal of RNA enhances binding of such cytosolic Gag to PC+PS liposomes (46) . 63
In good agreement with these studies, RNase treatment of cell homogenates derived from HIV-1-64 expressing cells resulted in significant shift of Gag from cytosolic to membrane fraction (47). These 65 observations suggest that WT Gag is susceptible to negative regulation of membrane binding by bound RNA and that Gag-membrane binding occurs only when this RNA is removed by RNase or 67 counteracted by PI(4,5)P2. Sequencing of RNAs cross-linked to MA revealed that the major RNA species 68 bound to MA in cells is tRNA and that MA-tRNA binding is reduced with membrane-bound Gag 69 compared to cytosolic Gag (47) . 70
Based on these studies, our working model is that RNA bound to MA-HBR prevents Gag from 71 electrostatically binding to acidic phospholipids such as PS, which are present ubiquitously in the cell 72 (51) . In this model, PI(4,5)P2 is able to overcome RNA-mediated negative regulation, thereby promoting 73 Gag binding to the PM, while RNA prevents Gag from binding to other acidic lipids present in non-PM 74 membranes (32, 44) . The hypothesis that MA-RNA binding prevents promiscuous localization of Gag has 75 not been directly investigated in the context of HIV-1 Gag expressed in cells. Our previous study of Gag 76 chimeras containing various retroviral MA domains showed the presence of a correlation between the 77 size of basic patches, RNA sensitivity in the in vitro liposome binding assay, and PM-specific Gag 78 localization in cells (29) . However, MA-RNA binding in cells was not measured in that study. Moreover, 79 confounding effects of structural variations of the various retroviral MA domains, other than the size of 80 the basic patches, cannot be excluded. In addition, although unlikely, it remains possible that Gag 81 chimeras with different retroviral MA domains may be differentially endocytosed after nascent virion 82 assembly at the PM, resulting in apparent differences in Gag localization. 83 In the current study, to examine the correlation between MA-RNA binding and subcellular Gag 84 localization while addressing the limitations in the previous studies, we compared the effects of two 85 types of amino acid substitutions in the context of HIV-1 MA-HBR and determined their ability to bind 86 RNA in cells and the specificity of their localization. The first type is Lys-to-Thr (KT) changes. We 87 previously showed that MA-HBR mutants with KT changes at MA residues 25 and 26 (25/26KT) or MA 88 residues 29 and 31 (29/31KT) display promiscuous subcellular localization to both PM and intracellular 89 membranes (14, 32) . As for MA-RNA binding, previous in vitro studies showed that KT mutations at 90 residues 25 and 26 (36) and Ala substitutions at any two or more MA-HBR basic residues (35) reduce 91 RNA binding to MA. In cells, a reduction in tRNA populations bound to Gag relative to total RNA 92 populations bound to Gag has been observed for KT mutations at residues 25 and 26 using 93 photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) followed by 94 sequencing (PAR-CLIP-Seq) (47). However, the magnitude of the effect of the HBR mutations on the RNA 95 binding ability of MA in cells remains to be determined. The second type of amino acid substitutions in 96 MA-HBR that we introduced is Lys-to-Arg (KR) changes, which do not affect the overall basic charge of 97 MA-HBR unlike the KT changes. Mutations that maintain the overall basic charge are expected to 98 preserve the RNA binding ability, since liposome binding of a mutant Gag in which all basic residues of 99 MA-HBR were switched (K->R and R->K) is still sensitive to RNA-mediated block of PC+PS liposome 100 binding (52). However, this prediction has neither been tested in cells nor tested for specific HBR 101 residues. 102
The comparison of HIV-1 Gag harboring the double amino acid substitutions in MA-HBR in this 103 study revealed that indeed basic-to-neutral changes in two Lys residues are sufficient to diminish MA-104 RNA binding in cells. Furthermore, unlike the KT mutants, which did not bind RNA via MA in cells and 105 were distributed to the PM as well as intracellular membranes, the KR mutants, which bound RNA, 106 showed little or no binding to intracellular membranes regardless of their PM localization. Altogether, 107 the strong correlation between MA-RNA binding and subcellular localization of Gag supports our 108 working model that MA-RNA binding inhibits promiscuous localization of Gag, thereby ensuring Gag 109 localization to the PM in the presence of PI(4,5)P2. The data obtained in this work also raise the 110 possibility that the interaction of MA-HBR residues with PI(4,5)P2 modulates a step beyond targeting 111 and binding of Gag to the PM. 112 113 114
Results 115
Gag derivatives with Lys-to-Arg (KR) changes in MA-HBR bind RNA more efficiently than those with 116
Lys-to-Thr (KT) changes in cells 117
To compare the RNA binding capacity of MA, we introduced three modifications into Gag 118 constructs. First is an MA amino acid substitution (1GA) that blocks N-terminal myristoylation and 119 thereby prevents Gag from binding membranes. The previous cell-based PAR-CLIP study (47) was 120 conducted using Gag constructs that can bind membranes, which would cause dissociation of RNA from 121 MA according to the model described above (see Introduction). Therefore, we eliminated membrane 122 binding so as to allow us to determine the total RNA binding capacity of Gag. Second, to focus on the 123 RNA binding ability of the MA domain, we deleted most of the NC domain (delNC), which is the major 124 RNA binding domain of Gag. Lastly, we fused YFP to the Gag C-terminus (Gag-YFP) to facilitate 125 microscopy analysis of the same constructs analyzed for MA-RNA binding. The 1GA/delNC/ constructs containing KR or KT mutations in MA residues 25 and 26 (25/26KR and 25/26KT) or MA 127 residues 29 and 31 (29/31KR and 29/31KT) ( Fig 1) were then compared with isogenic constructs with the 128 WT HBR sequence or a mutant HBR sequence in which all MA-HBR basic residues were switched to 129 neutral residues (6A2T). To determine the amount of RNA bound to MA in cells, we employed a 130 modified PAR-CLIP assay (47, 53) ( Fig 2) . HeLa cells were transfected with one of the constructs 131 with previous results (46), the Gag construct bearing 6A2T MA did not bind RNA efficiently, fold reduction in the amount of RNA bound relative to WT. Both the constructs bearing 25/26KT and 140 29/31KT MA bound significantly less RNA than the WT construct, similar to what was observed for 6A2T, 141 indicating that both Lys 25 and 26 and Lys 29 and 31 contribute to MA-RNA binding to similar extent in 142 cells. On the other hand, there was no statistically significant difference in the RNA binding efficiency 143 between the 25/26KR MA and the WT MA. The Gag construct with the other KR changes, 29/31KR, also 144 bound significantly more RNA compared to its KT counterpart, albeit less efficiently than WT. These 145 results indicate that the RNA binding efficiency of MA is dependent on the overall positive charge of the 146 MA-HBR basic patch. Additionally, the identity of basic amino acids at residues 29 and/or 31 also plays a 147 role in WT-level RNA binding. Having observed differential effects on MA-RNA binding between KR and 148 KT substitutions, we investigated below the correlation (or lack thereof) between MA-RNA binding and 149 subcellular localization of Gag, first focusing on the effects of the substitutions at MA residues 25/26, 150 and next on those at the residues 29/31. 151
Gag derivatives containing 25/26KR substitutions exhibit PM-specific localization unlike those with 152

25/26KT changes 153
To compare subcellular distribution of Lys 25/26 mutants, we expressed myristoylated and YFP-154 tagged Gag constructs bearing these changes, both in the full-length and delNC contexts, in HeLa cells 155 and observed the YFP localization in cells (Fig 3) . Based on the YFP distribution patterns, we identified 4 156 different phenotypes: (i) localization predominantly at the PM (green bar), (ii) localization to both PM 157 and intracellular compartments (blue bar), (iii) localization to only intracellular compartments (orange 158 bar), and (iv) only hazy cytosolic localization with no punctate intensities (pink bar). These 4 distribution 159 patterns were also validated by comparison of the YFP signal with that of Alexa Fluor 594-conjugated 160
Concanavalin A (ConA), which serves as the PM marker. As seen previously, the 25/26KT mutant bound 161 both PM and intracellular membranes. In contrast, the 25/26KR mutant presented PM-specific 162 localization similar to WT. Importantly for correlating the localization data with MA-RNA binding results 163 (Fig 2) , the subcellular localization patterns of delNC/Gag-YFP was similar to that of the corresponding 164 full-length Gag-YFP for both WT and the MA-HBR mutants. When we examined the VLP release 165 efficiency of full-length Gag-YFP construct, we found that despite the difference in subcellular 166 localization, both the Lys 25/26 mutants displayed robust VLP release efficiency compared to WT (Fig 4) . 167
A previous study showed that 25/26KT Gag produced in vitro using rabbit reticulocyte lysates binds 168 neutral PC-only liposomes efficiently, presumably due to enhanced myristate-driven hydrophobic 169 interactions (32). Using the same liposome binding assay, we found that the 25/26KR mutant also 170 exhibits increased hydrophobic interactions ( Fig 5A, 5B) . These data suggest that the enhanced VLP 171 release efficiency of Gag constructs with the Lys 25/26 substitutions is likely a result of increased 172 hydrophobic interactions (see Discussion). 173
25/26KR Gag is dependent on PI(4,5)P2 for efficient membrane binding unlike 25/26KT Gag 174
While 25/26KR MA shows WT-level RNA binding and mediates PM-specific localization of YFP, unlike WT MA it engaged in increased hydrophobic interactions with membranes similar to its 176 corresponding KT mutant MA (32) ( Fig 5A, 5B ). An earlier study has demonstrated that the 25/26KT 177 mutant exhibits increased PI(4,5)P2-independent liposome binding (32). Therefore, we examined 178 whether 25/26KR MA still shows PI(4,5)P2-dependent liposome binding. We found that the presence of 179 PI(4,5)P2 significantly increased the liposome binding efficiency of the 25/26KR mutant but does not 180 affect the 25/26KT mutant ( Fig 5C, 5D ). These results indicate that the 25/26KR mutant is dependent on 181 PI(4,5)P2 for efficient membrane binding unlike the 25/26KT mutant even though both showed 182 increased hydrophobic interactions relative to WT. 183 Upon depletion of cellular PI(4,5)P2, 25/26KR Gag-YFP exhibits promiscuous subcellular localization 184 PM localization of WT Gag is dependent on PI(4,5)P2 (15, 26, 27) . To investigate whether the 185 PM localization of 25/26KR Gag is also dependent on PI(4,5)P2, we next examined the effect of 186 expression of 5-phosphatase IV (5ptaseIV), which depletes cellular PI(4,5)P2, on subcellular distribution 187 of Gag-YFP derivatives. We co-expressed WT Gag-YFP or Gag-YFP with Lys 25/26 substitutions with full-188 length 5ptaseIV (FL) or its catalytically inactive derivative (Δ1) ( Fig 6) . As previously reported (26), WT 189
Gag-YFP lost PM-specific localization and displayed predominantly hazy cytosolic but sometimes 190 intracellular punctate distribution when co-expressed with FL 5ptaseIV. The 25/26KT mutant showed 191 predominantly promiscuous localization regardless of the presence of FL or Δ1 5ptaseIV, demonstrating 192 that this MA substitution mutant is not dependent on PI(4,5)P2 for cellular membrane binding. In 193 contrast, the localization of the 25/26KR mutant changed from predominantly PM-specific localization 194 to more promiscuous localization when it was co-expressed with the FL but not Δ1 5ptaseIV. These 195 results indicate that the PM-specific localization of the 25/26KR Gag is dependent on the presence of 196 PI(4,5)P2 in the cell. Overall, our results suggest that in the case of the Lys 25/26 mutants, Gag that 197 binds RNA efficiently maintains PI(4,5)P2-dependent PM-specific localization, while Gag that binds RNA 198 poorly shows PI(4,5)P2-independent promiscuous localization. Thus, for Lys 25/26 substitutions, there is 199 a correlation between RNA-binding and PI(4,5)P2-dependent PM-specific localization as observed with 200 Gag chimeras containing heterologous retroviral MA domains (29). 201
Gag derivatives containing 29/31KR substitutions show predominantly cytosolic distribution 202
Since 29/31KR MA exhibits significantly higher RNA binding than 29/31KT MA (Fig 2) , we next 203 sought to test whether RNA binding efficiency correlates with subcellular localization in the case of Gag 204 constructs containing changes at MA residues 29/31 as were observed for Gag mutants with changes at 205 residues 25/26. To this end, we first examined distribution of myristoylated full-length delNC/Gag-YFP derivatives (Fig 3) . Consistent with previous reports, Gag-YFP with the 29/31KT changes 207 displayed promiscuous localization with its signals present at both PM and intracellular membranes. 208 Interestingly, the 29/31KR mutant displayed a predominantly cytosolic distribution of Gag-YFP indicating 209 a loss of efficient membrane binding. It is important to note that unlike 29/31KT Gag-YFP, 29/31KR YFP showed negligible intracellular membrane binding despite having a higher positive charge than 211 29/31KT MA, which could mediate electrostatic interactions with acidic lipids more efficiently. We found 212 that both delNC and full-length Gag-YFP showed analogous subcellular patterns for each Lys 29/31 213 mutant. These results, together with the results of the comparison between two Lys 25/26 mutants, 214 strongly suggest that MA-RNA binding prevents Gag binding to intracellular membranes regardless of 215 whether Gag can bind the PM. In congruence with the microscopy results, we found that the VLP release 216 efficiency determined in the context of full-length Gag-YFP was significantly impaired for the 29/31KT 217 mutant and almost abolished for the 29/31KR mutant (Fig 4) . 218
Replacing the NC domain with a heterologous dimerization motif enables 29/31KR Gag-YFP to localize 219 specifically to the PM in a PI(4,5)P2-dependent fashion 220
Even though the lack of binding to intracellular membranes is a shared phenotype between 221 25/26KR Gag-YFP and 29/31KR Gag-YFP, 29/31KR Gag-YFP showed cytosolic distribution in most cells 222 unlike 25/26KR Gag-YFP. We hypothesized that 29/31KR Gag, unlike WT and 25/26KR Gag, is unable to 223 counteract the negative regulation of membrane binding by RNA that is bound to its MA-HBR. A 224 previous study suggests that while overall positive charge of HBR is sufficient for RNA-mediated 225 suppression of Gag-liposome binding irrespective of the identity of the residues, the identity of at least 226 one of the basic residues is important for MA-PI(4,5)P2 interaction (52). In addition, a recent NMR study 227 found that Lys 29 and 31 are important for binding of MA to PI(4,5)P2, even in an experimental system 228 in which RNA is absent (49). Based on these observations, we reasoned that due to attenuated MA-229 PI(4,5)P2 binding, 29/31KR Gag is unable to alleviate RNA-mediated suppression of membrane binding. 230
It is then conceivable, according to our model, that if membrane binding of this mutant Gag can be 231 enhanced enough to offset the negative regulation imposed by MA-RNA interactions, then this mutant 232 would localize specifically to the PM because MA-bound RNA would still prevent promiscuous 233 membrane binding. Multimerization increases binding of HIV-1 MA to the PM as well as to liposomes of 234 different compositions (48). Thus, we sought to test the hypothesis above by attempting to augment 235 multimerization of 29/31KR Gag. Previous studies reported that a leucine zipper dimerization motif (LZ) 236 promotes Gag multimerization more efficiently than the NC domain (55, 56) . Therefore, in order to 237 improve Gag multimerization, we replaced the NC domain of Gag with LZ (38, [57] [58] [59] [60] . We then 238 expressed WT and the Lys 29/31 substitution mutants in the context of Gag-YFP and GagLZ-YFP in cells 239 ( Fig 7) . We found that WT GagLZ-YFP predominantly localized at the PM as observed for WT The 29/31KT GagLZ-YFP showed a promiscuous localization like the 29/31KT Gag-YFP, indicating that 241 merely replacing the NC domain with LZ did not lead to the plasma membrane-specific localization. 242
Consistent with our prediction, the 29/31KR GagLZ-YFP demonstrated a markedly enhanced PM 243 localization compared to the 29/31KR Gag-YFP. Importantly, this construct showed very little 244 promiscuous localization unlike the 29/31KT GagLZ-YFP, suggesting that MA with 29/31KR changes 245 retains the ability to ensure PM-specific localization. Unexpectedly, the 29/31KR GagLZ-YFP still failed to 246 release VLPs efficiently (Fig 8) , suggesting that MA residues 29 and 31 play an additional role in assembly 247 beyond PM-specific binding. We then wanted to test directly in cells whether LZ-driven PM localization 248 is still PI(4,5)P2-dependent. To this end, we co-expressed GagLZ-YFP constructs with FL and Δ1 5ptaseIV 249 enzyme (Fig 9) . We found that both the WT GagLZ-YFP and 29/31KR GagLZ-YFP lost the PM-specific 250 localization when the FL 5ptaseIV enzyme was co-expressed. These results suggest that the WT GagLZ-251 YFP and the 29/31KR GagLZ-YFP bind the PM in a PI(4,5)P2-dependent manner. Interestingly, in the 252 presence of FL 5ptaseIV, WT GagLZ-YFP showed promiscuous localization to intracellular compartments 253 and the PM, whereas 29/31KR GagLZ-YFP showed predominantly cytosolic localization as observed for 254 WT Gag-YFP ( Fig 6) . Overall, the presented data suggest that when MA-HBR in Gag binds RNA, Gag 255 localizes specifically to the PM if it can counteract the RNA-mediated block on membrane binding either 256 via interaction with PI(4,5)P2, which occurs natively in the case of WT and 25/26KR Gag, or when 257 enhanced by improved multimerization as observed for 29/31KR GagLZ. In contrast, when Gag is 258 deficient in MA-RNA binding, it fails to localize specifically to the PM and instead, binds promiscuously to 259 different cellular membrane compartments. Altogether the analyses of Lys 25/26 and Lys 29/31 260 substitutions in MA-HBR revealed a strong correlation between MA-RNA binding and suppression of 261 non-specific Gag localization to intracellular membranes. 262
Discussion 263
In the current study, we examined the effects of amino acid substitutions in MA-HBR on the 264 relative amount of RNA bound to HIV-1 Gag in cells and on the subcellular localization of Gag. We found 265 that MA-HBR mutants that displayed a promiscuous subcellular localization (i.e., 25/26KT Gag and 266 29/31KT Gag) were incapable of binding RNA efficiently, consistent with earlier observations obtained 267 with Gag chimeras containing heterologous retroviral MA sequences (29). In contrast, MA-HBR mutants 268 that bound RNA efficiently did not show a promiscuous localization; they either localized specifically to 269 the PM (25/26KR Gag) or mainly remained in the cytosol (29/31KR Gag). The latter presented PM-270 specific and not promiscuous localization when its membrane binding ability was enhanced via LZ-271 mediated multimerization. The correlation established between MA-RNA binding and the lack of Gag 272 localization to intracellular membranes in this study further provides support for our current working 273 model of HIV-1 Gag assembly in which RNA-mediated inhibition of membrane binding of Gag prevents 274 non-specific localization of Gag to membranes other than the PM. 275
The liposome binding experiments using neutral liposomes indicate that 25/26KR Gag engages 276 in greater hydrophobic interactions with membranes than WT Gag, likely due to increased myristoyl 277 exposure relative to WT Gag. Combined with analogous results for 25/26KT Gag, first observed in our 278 previous study (32), these results support that Lys 25 and 26 play a role in myr exposure regulation. 279
Despite the enhanced hydrophobic interactions with membranes, 25/26KR Gag maintains PM-specific 280 localization like WT Gag. However, the outcomes of PI(4,5)P2 depletion differ between WT and 25/26KR 281 Gag. Upon FL 5ptaseIV expression, WT Gag loses membrane binding and exhibits predominantly 282 cytosolic distribution, whereas 25/26KR Gag retains membrane binding albeit localizing promiscuously in 283 the majority of the Gag-YFP expressing cells. Therefore, RNA binding alone is likely sufficient for 284 preventing promiscuous binding of WT Gag to intracellular membranes, but the presence of PI(4,5)P2 is 285 necessary when membrane binding is enhanced beyond the WT level. The two different outcomes of 286 PI(4,5)P2 depletion also highlights the two functions of PI(4,5)P2, enhancing membrane binding of Gag 287 and supporting PM-specific localization. 288
We found that 25/26KR Gag exhibits increased VLP release efficiency compared to WT Gag, 289 likely due to enhanced membrane binding as discussed above. Therefore, the Lys-to-Arg mutation at 290 residues 25 and 26 should confer fitness advantage to HIV-1. However, Lys 25 and 26 are highly 291 conserved across various clades of HIV-1 (61). We speculate that Arg, instead of Lys, at positions 25 and 292 26 may negatively affect other aspects of the HIV-1 life cycle. Similar to 25/26KR Gag, 25/26KT Gag also 293 shows superior VLP release efficiency even though 25/26KT Gag does not localizes specifically to the PM 294 unlike its KR counterpart. The high VLP release efficiency of 25/26KT Gag may be due to even more 295 robust hydrophobic interactions with membranes than 25/26KR Gag (Fig 5) , which may make up for the 296 Gag mislocalization. The increased hydrophobic interactions of 25/26KT Gag, which does not bind RNA, 297 is consistent with the observation that removal of RNA increases hydrophobic interactions in a myr-298 dependent manner (32). 299
We found that RNA binding of 29/31KR Gag was not as efficient as WT Gag although it was 300 better than that of 29/31KT Gag. While we observed previously that RNA sensitivity of binding is maintained when all Lys and Arg in MA-HBR are switched with each other (52), the presence 302 of Lys, but not Arg, at residues 29 and 31 seems to be important for WT-level RNA binding of Gag. While 303 both Arg and Lys are positively charged basic amino acids, Arg has a terminal guanidium group, while Lys 304 has a single terminal amino group. These groups also differ in their geometry (i.e., planar versus 305 tetrahedral). Therefore, it is possible that Lys and Arg participate in different number and/or orientation 306 of electrostatic interactions with RNA or lipids (62-65). 307
Even though 29/31KR Gag showed reduced RNA binding, this level of MA-RNA binding was 308 sufficient for suppressing binding to intracellular membranes. It is noteworthy that 29/31KR Gag failed 309 to bind even the PM in most cells. Strongly cationic model proteins have been shown to associate with 310 the PM (54). However, in the case of HIV-1 Gag, the high positive charge retained in 29/31KR MA is 311 insufficient for the PM localization, likely due to the RNA-mediated block. As mentioned above, Lys 29 312 and 31, especially 31, are important for PI(4,5)P2 interaction even in the absence of RNA (49). Based on 313 this knowledge, we speculate that due to inefficient interaction with PI(4,5)P2, 29/31KR Gag is unable to 314 overcome the negative regulation by RNA. Therefore, the balance between MA-RNA and MA-PI(4,5)P2 315 binding, which is carefully orchestrated for WT Gag, is tipped in the favor of MA-RNA binding in case of 316 29/31KR Gag. It is likely that the enhanced multimerization of 29/31KR Gag through the LZ dimerization 317 motif restores the balance toward MA-PI(4,5)P2 binding, leading to PM-specific localization of 29/31KR 318 GagLZ. Probable mechanisms through which LZ may promote membrane binding may be an avidity 319 effect, induction of myristate exposure (22), a reduction in the amount of RNA bound to MA associated 320 with myristate exposure (66), or some combination of these factors. 321
Notably, there is no commensurate increase in VLP release for 29/31KR GagLZ compared to 322 29/31KR despite the dramatic shift in Gag localization from the cytosol to the PM. It is conceivable that 323 the 29/31KR mutation causes not only a membrane-binding defect but an additional cryptic defect that 324 is revealed only in the LZ context. Since 29/31KR GagLZ is recruited to the PM, the defect is likely at an 325 assembly step after targeting and binding of Gag to the PM. Analogous to our observation, a recent 326 study found that when the MA domain of HIV-1 Gag was replaced with the N-terminal PI(4,5)P2 binding 327 region of avian sarcoma virus Gag, the chimeric Gag localized to the PM but did not release VLP 328 efficiently (67). The order of Gag-PM binding and multimerization into Gag puncta varies between 329 different retroviruses (68). The majority of HIV-1 Gag is directly recruited to Gag puncta at the PM from 330 the cytosol rather than after binding elsewhere on the PM (68, 69). Thus, it is possible that a change in 331 this order due to the LZ substitution of NC may have made a step in VLP assembly, such as membrane 332 curvature, more dependent on the native sequence of MA-HBR. It is known that unsaturated acyl chains 333 favor membrane curvature (70). Previous in vitro studies have shown that HIV-1 Gag is sensitive to acyl 334 chain saturation of phospholipids and prefers PI(4,5)P2 with unsaturated acyl chains (71, 72). Acute 335 PI(4,5)P2 depletion studies revealed that Gag continues to interact with PI(4,5)P2 after initial membrane 336 binding of Gag and Gag multimerization (73) . Altogether, we speculate that the orientation of MA basic 337 amino acids at the interface between the PM and Gag lattice may play a key role in interactions with 338 PI(4,5)P2 or other acidic lipids with different acyl chains and hence, in promotion of membrane 339 curvature. 340
Overall, this paper provides a strong correlation between the ability of HIV-1 Gag to bind RNA 341 via MA and the specificity of Gag localization to the PM. In the absence of PI(4,5)P2, WT Gag and 342 29/31KR GagLZ remain in the cytosol (Figs 6 and 9 ). Therefore, RNA binding is likely sufficient for 343 preventing non-specific binding to other membranes for these Gag proteins. On the other hand, 344 25/26KR Gag and WT GagLZ, which are likely to have higher affinities to lipid bilayers due to increased 345 myristoyl exposure or avidity, show promiscuous localization upon PI(4,5)P2 depletion (Fig 6 and 9) . In 346 these cases, both RNA and PI(4,5)P2 likely work in conjunction to prevent promiscuous localization. manner, was constructed as described previously for pCMVNLGagPolRRE using standard 354 molecular cloning techniques. pCMVNLGagPolRRE delNC/Gag-YFP was generated by replacing the SpeI-355
XmaI region of pCMVNLGagPolRRE (75) with the corresponding region of pNL4-3/delNC/ . 1GA mutation was introduced into the pCMVNLGagPolRRE delNC/ constructs by PCR mutagenesis as described before (74) pCMVNL GagLZ-YFP (previously named 358 pCMVNLGag Venus LZ) was described in prior reports Gag (29, 52) . pGEMNLNR, an expression vector 359 used for in vitro transcription and translation of Gag, was described previously (26) . To create 360 pCMVNLGagPolRRE 25/26KR Gag-YFP and pCMVNLGagPolRRE 29/31KR Gag-YFP, the corresponding MA-361 HBR point mutations were introduced using PCR mutagenesis into pCMVNLGagPolRRE pCMVNLGagPolRRE 25/26KT Gag-YFP and pCMVNLGagPolRRE 29/31KT Gag-YFP were constructed by 363 replacing the SpeI-BssHII region of pCMVNLGagPolRRE Gag-YFP with corresponding region of 364 pGEMNLNR 25/26KT Gag and pGEMNLNR 29/31KT Gag (26, 32) . pCMVNLGagPolRRE delNC/ containing the MA-HBR mutations, i.e., 25/26KR, 25/26KT, 29/31KR and 29/31KT, were constructed 366 using standard molecular cloning techniques. pCMVNLGagPolRRE 6A2T delNC/Gag-YFP was created by 367 replacing the SpeI-BssHII region of pCMVNLGagPolRRE delNC/Gag-YFP with corresponding region of 368 pGEMNLNR 6A2T Gag (26, 32) . pGEMNLNR containing the MA-HBR mutations, i.e., 25/26KR and 369 29/31KR, were constructed using standard molecular biology techniques. pCMVNL GagLZ-YFP containing 370 the MA-HBR mutations, i.e., 25/26KR, 25/26KT, 29/31KR and 29/31KT; and pGEMNLNR containing the 371 MA-HBR mutations, i.e., 25/26KR and 29/31KR, were constructed using standard molecular cloning 372 techniques. 373 pCMV-Rev was described previously (74) (kindly provided by S. Venkatesan, National Institutes 374 of Health). A mammalian expression plasmid encoding myc-tagged 5-phosphatase IV (FL 5ptaseIV), 375 pcDNA4TO/Myc5ptaseIV, and its catalytically inactive Δ1 derivative (Δ1 5ptaseIV) were previously 376 described (26, 77) . pCMV-Vphu, which encodes the codon-optimized version of the HIV-1 Vpu gene, was 377 previously described (78) (a kind gift from K. Strebel ). 378
Cells and transfection. 379
HeLa cells were cultured as described previously (32 Olympus IX70 inverted fluorescence microscope at 60x magnification, and a range of 37 to 134 cells 398 were evaluated for Gag localization pattern. For 5ptaseIV coexpression studies, only cells that were 399 positive for both Gag and 5ptaseIV (either FL or Δ1) were chosen for evaluation. Confocal microscopy 400 using Leica SP5 Inverted confocal microscope was carried out to further verify localization patterns 401 determined by epifluorescence microscopy. 402
Liposome-binding assay. 403
Preparation of liposomes, in vitro Gag translation, and sucrose gradient flotation centrifugation were 404 performed as described previously (32). In brief, full-length myristoylated Gag was translated in vitro 405 using Promega's TnT Sp6 Coupled Reticulocyte Lysate System and incubated with sonicated liposomes 406 composed of a neutral lipid, phosphatidylcholine, and an acidic lipid, phosphatidylserine, in a 2:1 molar 407 ratio (PC+PS [2:1] liposomes) with or without addition of 7.25 mol% PI(4,5)P2. Following sucrose 408 flotation centrifugation, five fractions were collected with the top two fractions representing the 409 membrane bound, floating Gag. Following SDS-PAGE, Gag bands were detected by phosphorimager 410 analysis and quantified using ImageQuant 1D TL v8.1 image analysis software. Liposome binding 411 efficiency (%) was calculated as the percentage of membrane bound Gag versus the total Gag in all 5 412 fractions. 413
PAR-CLIP assay. 414
To determine the amount of cellular RNA bound to transfected Gag, the PAR-CLIP assay was performed 415 as described before (47, 53) with some modifications. Briefly, in a 6-well plate, 4X10 5 HeLa cells were 416 cultured in DMEM supplemented with 5% fetal bovine serum in the presence of penicillin and 417 streptomycin antibiotics. The cells were then transfected with either a plasmid encoding 418 1GA/delNC/Gag-YFP containing the indicated MA sequence or pUC19. The cells were cultured for 24 hrs 419 post transfection before addition of fresh media containing 100 µM 4-thiouridine (4-SU, Sigma), a photo-420 crosslinkable ribonucleoside analogue. After 16 hours, the cells were exposed to 354nm UV light at 421 300mJ/cm 2 to crosslink RNA and RNA-binding proteins. Cells were lysed with NP-40 lysis buffer ( shaking at 1400 RPM. After resolving the bands by SDS-PAGE and subsequent electrotransfer to a PVDF 432 membrane, the membrane was probed with HIV-Ig as the primary antibody and corresponding 433 secondary antibody conjugated to horseradish peroxidase (goat anti-human IgG, Invitrogen). specific bands were detected after incubation with SuperSignal West Pico chemiluminescent substrate 435 (Pierce) on Syngene Pxi multiapplication imager, and the intensity of the bands were measured using 436 GeneTools analysis software. The 32 P end-labeled RNA bands were also detected on the same 437 membrane using autoradiography on the Typhoon FLA 9500 laser scanner and quantified using 438 ImageQuant 1D TL v8.1 image analysis software. The relative RNA binding efficiency (%) was calculated 439 as the percentage of total RNA band intensity versus the total Gag band intensity for each construct and 440 compared to the normalized value for WT 1GA/delNC/ 
Statistical analysis. 442
Student's t-tests were performed using Graphpad Prism. P values of <0.05 were considered statistically 443 significant. 444 445 ACKNOWLEDGMENTS 446
We thank our fellow laboratory members for helpful discussions and critical reviews of the manuscript. 447
We thank S. Kutluay 
